Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Announces Investor Relations (IR) Event for Q3 2024 Earnings Release

Posted on October 15, 2024July 21, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Announces Investor Relations (IR) Event for Q3 2024 Earnings Release

Source Facts: Financial Supervisory Service DART / 2024-10-15

Disclosure Type: Investor Relations (IR) Announcement

💡 3-Second Summary

Hanwha Aerospace will hold an IR event for domestic institutional investors from November 1 to November 6, 2024, to present its Q3 2024 financial results and outlook.

📊 1. Key Disclosure Details & Major Figures

  • Event Name: Q3 2024 Earnings Release IR
  • Date & Schedule: November 01, 2024 – November 06, 2024
  • Location & Format: Key domestic investment institutions (Yeouido, Seoul, etc.) / 1-on-1 meetings and group conference calls
  • Target Audience: Domestic institutional investors
  • Purpose: Enhance investor understanding through Q3 2024 financial result presentations
  • Sponsor: Sangsangin Securities
  • Key Topics: Q3 2024 operating results, business outlook, and Q&A
  • IR Material Posting Date: October 31, 2024 (via official website)
  • Official Website: https://www.hanwhaaerospace.com

📈 2. Expert Perspective: What This Disclosure Means for Investors

This filing provides advance notification of Hanwha Aerospace’s schedule for its regular investor relations event, arranged to coincide with the release of its third-quarter 2024 financial results for domestic institutional investors.

The underlying IR presentations will be posted on the company’s official website on October 31, 2024, followed by investor meetings held between November 1 and November 6. Market participants can cross-reference the IR materials published on October 31 with management’s commentary during the meetings to evaluate key segment drivers and forward guidance.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Aerospace has scheduled its Q3 2024 investor relations sessions following the publication of earnings slides on October 31. Direct institutional engagement will take place over the following business days through November 6.

Key observation points for market participants include analyzing the financial details uploaded on October 31 and monitoring management commentary regarding defense backlog execution and medium-term margin trajectories.

📢 Disclaimer & Source Notice

Source: This content was structured and newly compiled based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) Formally Amends Monetary Loan Value Upward to KRW 234.2B for Singapore Affiliate
Next Post: [Disclosure] Hanwha Aerospace (012450) Announces Investor Relations (IR) Conference Call & Webcast for Q3 2024 Earnings Release

Related Posts

[Disclosure] Celltrion (068270) to List 41,475 Additional Common Shares Following Exercise of Stock Options Disclosures
[Disclosure] Hanwha Ocean (042660) to Hold Corporate Briefing (IR) for Q1 2026 Earnings Release on April 27 Disclosures
[Disclosure] Celltrion (068270), Obtains Final Marketing Authorization from the European Commission (EC) for Steqeyma (CT-P43) Disclosures
[Disclosure] Isu Petasys (007660) Sets 1st Rights Offering Price at KRW 33,500; Final Price to be Locked on April 7 Semiconductors
[Disclosure] Hanamicron(067310) Announces Concurrent Paid-in(5M shares) and Bonus Issue Strategy Semiconductors
[Disclosure] Celltrion (068270) Obtains MFDS Approval for Phase 3 Clinical Trial Plan of ‘CT-P51’ (Keytruda Biosimilar) in South Korea Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme